Literature DB >> 20611032

Progestogen-only injectable hormonal contraceptive use should be considered in analysis of studies addressing the loss of bone mineral density in HIV-positive women.

Mags E Beksinska, Jennifer A Smit, Arthi Ramkissoon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20611032     DOI： 10.1097/QAI.0b013e3181e49462

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  3 in total

1.  Contraception in HIV-positive female adolescents.

Authors:  Nadia T Kancheva Landolt; Sudrak Lakhonphon; Jintanat Ananworanich
Journal:  AIDS Res Ther       Date:  2011-06-01       Impact factor: 2.250

2.  Contraceptive challenges in adolescents living with or at risk of HIV.

Authors:  Nadia Kancheva Landolt; Torsak Bunupuradah; Surasith Chaithongwongwatthana
Journal:  J Virus Erad       Date:  2016-04-01

3.  Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception.

Authors:  Nadia Kancheva Landolt; Torsak Bunupuradah; Jullapong Achalapong; Pope Kosalaraksa; Witaya Petdachai; Chaiwat Ngampiyaskul; Sasiwimol Ubolyam; Narukjaporn Thammajaruk; Stephen Kerr; Jintanat Ananworanich
Journal:  J Virus Erad       Date:  2017-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.